Obagi Medical Products, Inc. (NASDAQ:OMPI) Investor Alert: Lawsuit to Halt Takeover Filed
An investor in shares of Obagi Medical Products, Inc. (NASDAQ:OMPI) filed a lawsuit to halt the takeover of Obagi Medical Products, Inc. by Valeant Pharmaceuticals International at $19.75 per NASDAQ:OMPI share.
View full press release